Δ9-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture

Molecular Pharmacology

Volumn 55, Issue 1, 1999, Pages 8-13

  Shen, Maoxing ^a   Thayer, Stanley A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CALCIUM ION; CANNABINOID RECEPTOR; CANNABIS; DRONABINOL; INDO 1; MAGNESIUM; RIMONABANT; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; GLUTAMIC ACID; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DEPENDENCE; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MICROFLUOROMETRY; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTIC TRANSMISSION; ANIMAL; CELL CULTURE; DRUG EFFECT; METABOLISM; SECRETION;

ANIMALS; CALCIUM; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; MAGNESIUM; RATS; SYNAPTIC TRANSMISSION; TETRAHYDROCANNABINOL;

EID: 0032589801     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.1.8     Document Type: Article

References (38)

1. Abood ME and Martin BR (1992) Neurobiology of marijuana abuse. Trends Pharmacol Sci 13:201-206.
2. Adams IB and Martin BR (1996) Cannabis: Pharmacology and toxicology in animals and humans. Addiction 91:1585-1614.
3. Breivogel CS, Sim LJ and Childers SR (1997) Regional differences in cannabinoid receptor G-protein coupling in rat brain. J Pharmacol Exp Ther 282:1632-1642.
4. Burkey TH, Quock RM, Consroe P, Ehlert FJ, Hosohata Y, Roeske WR and Yamamura HI (1997a) Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur J Pharmacol 336:295-298.
5. Burkey TH, Quock RM, Consroe P, Roeske WR and Yamamura HI (1997b) Δ(9)-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Eur J Pharmacol 323:R3-R4.
6. Childers SR, Pacheco MA, Bennett BA, Edwards TA, Hampson RE, Mu J and Deadwyler SA (1993) Cannabinoid receptors: G-protein-mediated signal transduction mechanisms. Biochem Soc Symp 59:27-50.
7. Compton DR, Johnson MR, Melvin LS, and Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260:201-209.
8. D'Ambra TE, Estep KG, Bell MR, Eissenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casiano FM, Beglin NC, Chippari SM, Grego JD, Kullnig RK and Daley GT (1992) Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J Med Chem 35:124-135.
9. De Lean A, Munson PJ and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.
10. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ and Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1:121-134.
11. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AS (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
12. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
13. Henry DJ and Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94.
14. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR and Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
15. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20.
16. Howlett A (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
17. Johnson MR and Melvin LS (1986) The discovery of nonclassical cannabinoid analgetics, in Cannabinoids as Therapeutic Agents (Mechoulam R ed) pp 121-145, CRC Press, Boca Rotan, FL.
18. Lake KD, Compton DR, Varga K, Martin BR and Kunos G (1997) Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-1037.
19. Lichtman AH and Martin BR (1996) Δ(9)-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacol 126:125-131.
20. Mackie K, Devane WA and Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
21. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
22. Mackie K, Lai Y, Westenbroek R and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
23. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (London) 346:561-564.
24. McLeod JR, Shen M, Kim DJ and Thayer SA (1998) Neurotoxicity mediated by aberrant patterns of synaptic activity between rat hippocampal neurons in culture. J Neurophysiol 80:2688-2698.
25. Oviedo A, Glowa J and Herkenham M (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study. Brain Res 616:293-302.
26. + + channels in a neuronal expression system. Mol Pharmacol 49:707-714.
27. Plasse TF, Gorter RW, Krasnow SH, Lane M, Shepard KV and Wadleigh RG (1991) Recent clinical experience with dronabinol. Pharmacol Biochem Behav 40:695-700.
28. Shen M, Piser TM, Seybold VS and Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
29. Shen M and Thayer SA (1996) Desensitization of cannabinoid-mediated inhibition of glutamatergic synaptic transmission between cultured hippocampal neurons. Soc Neurosci Abst 22:82.
30. Shen M and Thayer SA (1998) The cannabinoid agonist Win55212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783:77-84.
31. Sim LJ, Hampson RE, Deadwyler SA and Childers SR (1996a) Effects of chronic treatment with Δ(9)-tetrahydrocannabinol on cannabinoid-stimulated [S-35]GTP-γ-S autoradiography in rat brain. J Neurosci 16:8057-8066.
32. Sim LJ, Selley DE, Dworkin SI, and Childers SR (1996b) Effects of chronic morphine administration on Mu opioid receptor-stimulated [S-35]GTP-γ-S autoradiography in rat brain. J Neurosci 16:2684-2692.
33. + + transients using simultaneous microfluorimetry and electrophysiology. Pflugers Arch 412:216-223.
34. Tsou K, Brown S, Sanudo-Pena MC, Mackie K and Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
35. Tsou K, Patrick SL and Walker JM (1995) Physical withdrawal in rats tolerant to Δ(9)-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280:13-15.
36. Twitchell W, Brown S and Mackie K (1997) Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78:43-50.
37. + + loads. J Neurophysiol 72:2563-2569.
38. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996) The cubic ternary complex receptor-occupancy model III resurrecting efficacy. J Theor Biol 181:381-397.